Regeneron Pharmaceuticals, Inc. company logo
Regeneron Pharmaceuticals, Inc. logo

REGN EBIT

Annual EBIT

$4.84B$562.80M+13.17%

Summary

Current Value
As of today, REGN annual EBIT is $4.84B, up +13.17% on
Historical Performance
REGN annual EBIT is down -48.47% over the past 3 years, and up +96.60% over the past 5 years
All-Time High Comparison
REGN annual EBIT is currently -48.47% below its historical high of $9.38B set on
3-Year Low Comparison
REGN annual EBIT is +13.17% above its 3-year low of $4.27B reached on
Sector Comparison
REGN annual EBIT is higher than 98.14% of companies in Healthcare sector

EBIT Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

REGN Performance
MetricDateValue1Y3Y5Y15Y
Annual EBIT$4.84B+13.2%-48.5%+96.6%+7045.5%
Quarterly EBIT$1.11B-10.2%-9.3%+5.4%+3558.3%
TTM EBIT$3.83B-7.5%-40.7%+24.1%+3191.6%
Price$796.55+8.6%+17.1%+59.7%+2235.9%
PE Ratio19.07-0.5%+7.2%+17.3%
Annual Revenue$14.20B+8.3%-11.6%+116.6%+3644.6%
Annual EPS$38.34+10.3%-46.7%+107.7%+4610.3%
Annual EBITDA$5.32B+13.3%-45.0%+99.2%+9704.8%
Annual Net Income$4.41B+11.6%-45.4%+108.5%+6605.4%

EBIT Highs

REGN Annual EBIT Highs Comparison
PeriodHighDateCurrent
3Y$4.92BN/A-1.7%
5Y$9.38B-48.5%
All$9.38B-48.5%

EBIT Lows

REGN Annual EBIT Lows Comparison
PeriodLowDateCurrent
3Y$4.27B+13.2%
5Y$3.87BN/A+25.0%
All-$201.61M+2498.2%

EBIT History

YearValueChange
$4.84B+13.2%
$4.27B-13.1%
$4.92B-47.6%
$9.38B+142.6%
$3.87B+57.3%
$2.46B-4.7%
$2.58B+22.7%
$2.10B+57.3%
$1.34B+7.9%
$1.24B+55.2%
$798.61M+7.5%
$742.82M+61.6%
$459.73M+328.0%
-$201.61M-111.4%
-$95.35M-37.0%
-$69.62M-0.9%
-$69.03M+26.2%
-$93.56M+13.1%
YearValueChange
-$107.66M-186.5%
$124.42M+2,103.7%
$5.65M+105.6%
-$99.99M+18.0%
-$121.95M-42.3%
-$85.68M-239.0%
-$25.28M-6.2%
-$23.80M-90.4%
-$12.50M+8.8%
-$13.70M+20.8%
-$17.30M-127.6%
-$7.60M+74.0%
-$29.20M+24.7%
-$38.80M-112.0%
-$18.30M-90.6%
-$9.60M-190.9%
-$3.30M-

FAQ

  • What is the current annual EBIT of REGN?

    As of today, REGN annual EBIT is $4.84B

  • What is 1-year change in REGN annual EBIT?

    REGN annual EBIT is up +13.17% year-over-year

  • What is 3-year change in REGN annual EBIT?

    REGN annual EBIT is down -48.47% over the past 3 years

  • How far is REGN annual EBIT from its all-time high?

    REGN annual EBIT is currently -48.47% below its historical high of $9.38B set on December 31, 2021

  • How does REGN annual EBIT rank versus sector peers?

    REGN annual EBIT is higher than 98.14% of companies in Healthcare sector

  • When is REGN next annual earnings release?

    The next annual earnings release for REGN is on

EBIT Formula

EBIT = Revenue

Data Sources & References

  1. REGN Official Website www.regeneron.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/872589/000087258925000028/0000872589-25-000028-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/872589/000180422025000011/0001804220-25-000011-index.htm
  4. REGN Profile on Yahoo Finance finance.yahoo.com/quote/REGN
  5. REGN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/regn